Abstract
Purpose
The aim of this study is to evaluate the efficacy of intracameral preservative-free triamcinolone acetonide (TA) on reducing inflammatory reactions after pediatric cataract surgery.
Methods
Researches were comprehensively searched in PubMed, Embase, and the Cochrane Central Register of Controlled Trials up to 30 November, 2019. Data of interest were extracted and analyzed by Review Manager 5.2. The primary outcome was cell deposits. The secondary outcomes included posterior synechias, fibrinous anterior chamber reaction, visual axis obscuration, and posterior capsule opacification. The odds ratio (OR), weight mean difference (WMD), and their 95% confidence intervals (95% CI) were used to assess the strength of the association.
Results
In total, 45 articles were obtained. Finally, 5 studies with a total of 308 eyes were enrolled in this meta-analysis. Among these, 134 eyes underwent intracameral TA treatment and 174 eyes did not. In intracameral TA treatment group, the incidence of cell deposits (OR = 0.35, 95% CI 0.16–0.76, P = 0.008), posterior synechias (OR = 0.44, 95% CI 0.23–0.86, P = 0.02), and fibrinous anterior chamber reaction (OR = 0.12, 95% CI 0.01–1.05, P = 0.05) were lower compared to those in patients without intracameral TA treatment. Meanwhile, the incidence of visual axis obscuration (OR = 0.10, 95% CI 0.01–0.85, P = 0.04) and posterior capsule opacification (OR = 0.09, 95% CI 0.02–0.55, P = 0.009) were also reduced significantly. The intraocular pressure (IOP) was evaluated at the first month postoperatively (WMD = 0.84 mmHg, 95% CI 0.14–1.53, P = 0.02), but within the normal range. There was no difference of IOP between two groups at 6 months or above after operation (P = 0.93).
Conclusions
The intracameral preservative-free TA in pediatric cataract surgery contributed to much less inflammatory reaction with the normal IOP range.
Similar content being viewed by others
References
Sheeladevi S, Lawrenson JG, Fielder AR, Suttle CM (2016) Global prevalence of childhood cataract: a systematic review. Eye (Lond) 30:1160–1169. https://doi.org/10.1038/eye.2016.156
Medsinge A, Nischal KK (2015) Pediatric cataract: Challenges and future directions. Clin Ophthalmol 9:77–90. https://doi.org/10.2147/OPTH.S59009
Wong IB, Sukthankar VD, Cortina-Borja M, Nischal KK (2009) Incidence of early-onset glaucoma after infant cataract extraction with and without intraocular lens implantation. Br J Ophthalmol 93:1200–1203. https://doi.org/10.1136/bjo.2008.155200
Basti S, Ravishankar U, Gupta S (1996) Results of a prospective evaluation of three methods of management of pediatric cataracts. Ophthalmology 103:713–720. https://doi.org/10.1016/s0161-6420(96)30624-6
Ram J, Brar GS, Kaushik S, Gupta A, Gupta A (2003) Role of posterior capsulotomy with vitrectomy and intraocular lens design and material in reducing posterior capsule opacification after pediatric cataract surgery. J Cataract Refract Surg 29:1579–1584. https://doi.org/10.1016/s0886-3350(03)00231-1
Yamakiri K, Uchino E, Kimura K, Sakamoto T (2004) Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery. Am J Ophthalmol 138:650–652. https://doi.org/10.1016/j.ajo.2004.05.033
Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554–555. https://doi.org/10.1097/00006982-200005000-00024
Shah SK, Vasavada V, Praveen MR, Vasavada AR, Trivedi RH, Dixit NV (2009) Triamcinolone-assisted vitrectomy in pediatric cataract surgery. J Cataract Refract Surg 35:230–232. https://doi.org/10.1016/j.jcrs.2008.10.037
Negi AK, Browning AC, Vernon SA (2006) Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J Cataract Refract Surg 32:468–474. https://doi.org/10.1016/j.jcrs.2005.12.102
Cleary CA, Lanigan B, O'Keeffe M (2010) Intracameral triamcinolone acetonide after pediatric cataract surgery. J Cataract Refract Surg 36:1676–1681. https://doi.org/10.1016/j.jcrs.2010.04.038
Smithen LM, Ober MD, Maranan L, Spaide RF (2004) Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138:740–743. https://doi.org/10.1016/j.ajo.2004.06.067
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 62:1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005
Allam G, Ellakkany R, Ellayeh A, Mohsen T, Abouelkheir HE, Gaafar W (2018) Outcome of pediatric cataract surgery with intraocular injection of triamcinolone acetonide: Randomized controlled trial. Eur J Ophthalmol 28:633–638. https://doi.org/10.1177/1120672117754168
Gupta R, Ram J, Sukhija J, Singh R (2014) Outcome of paediatric cataract surgery with primary posterior capsulotomy and anterior vitrectomy using intra-operative preservative-free triamcinolone acetonide. Acta Ophthalmol 92:e358–e361. https://doi.org/10.1111/aos.12375
Ventura MC, Ventura BV, Ventura CV, Ventura LO, Arantes TE, Nose W (2014) Outcomes of congenital cataract surgery: Intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. J Cataract Refract Surg 40:601–608. https://doi.org/10.1016/j.jcrs.2013.09.011
Mohamed TA, Soliman W, Fathalla AM (2016) Effect of intracameral triamcinolone acetonide on postoperative intraocular inflammation in pediatric traumatic cataract. Eur J Ophthalmol 26:114–117. https://doi.org/10.5301/ejo.5000648
Dixit NV, Shah SK, Vasavada V, Vasavada VA, Praveen MR, Vasavada AR, Trivedi RH (2010) Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes. J Cataract Refract Surg 36:1494–1498. https://doi.org/10.1016/j.jcrs.2010.03.040
Van Looveren J, Ni DS, Godts D, Bakker E, De Veuster I, Mathysen DG, Tassignon MJ (2015) Pediatric bag-in-the-lens intraocular lens implantation: long-term follow-up. J Cataract Refract Surg 41:1685–1692. https://doi.org/10.1016/j.jcrs.2014.12.057
Gasper C, Trivedi RH, Wilson ME (2016) Complications of pediatric cataract surgery. Dev Ophthalmol 57:69–84. https://doi.org/10.1159/000442502
Karalezli A, Borazan M, Akova YA (2008) Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol 86:183–187. https://doi.org/10.1111/j.1600-0420.2007.01114.x
Steven DW, Alaghband P, Lim KS (2018) Preservatives in glaucoma medication. Br J Ophthalmol 102:1497–1503. https://doi.org/10.1136/bjophthalmol-2017-311544
Yu SH, Drucker AM, Lebwohl M, Silverberg JI (2018) A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol 78:733–740. https://doi.org/10.1016/j.jaad.2017.09.074
Sakamoto T, Ishibashi T (2009) Visualizing vitreous in vitrectomy by triamcinolone. Graefes Arch Clin Exp Ophthalmol 247:1153–1163. https://doi.org/10.1007/s00417-009-1118-2
Kaynak S, Celik L, Kocak N, Oner FH, Kaynak T, Cingil G (2006) Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation. J Cataract Refract Surg 32:56–59. https://doi.org/10.1016/j.jcrs.2005.10.028
Li J, Heinz C, Zurek-Imhoff B, Heiligenhaus A (2006) Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis. J Cataract Refract Surg 32:1535–1539. https://doi.org/10.1016/j.jcrs.2006.04.018
Tao Y, Jonas JB (2011) Intravitreal triamcinolone. Ophthalmologica 225:1–20. https://doi.org/10.1159/000317909
Philip SS, Braganza AD, Rebekah GJ (2019) Comparison of a single intraoperative posterior sub-Tenon's capsule triamcinolone acetonide injection versus topical steroids for treatment of postcataract surgery inflammation in children. Oman J Ophthalmol 12:25–30. https://doi.org/10.4103/ojo.OJO_147_2017
Sharma N, Pushker N, Dada T, Vajpayee RB, Dada VK (1999) Complications of pediatric cataract surgery and intraocular lens implantation. J Cataract Refract Surg 25:1585–1588
Hosal BM, Biglan AW (2002) Risk factors for secondary membrane formation after removal of pediatric cataract. J Cataract Refract Surg 28:302–309. https://doi.org/10.1016/s0886-3350(01)01028-8
Tsai TH, Tsai CY, Huang JY, Hu FR (2017) Outcomes of pediatric cataract surgery with triamcinolone-assisted vitrectomy. J Formos Med Assoc 116:940–945. https://doi.org/10.1016/j.jfma.2017.01.009
Jermak CM, Dellacroce JT, Heffez J, Peyman GA (2007) Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 52:503–522. https://doi.org/10.1016/j.survophthal.2007.06.004
Inatani M, Iwao K, Kawaji T, Hirano Y, Ogura Y, Hirooka K, Shiraga F, Nakanishi Y, Yamamoto H, Negi A, Shimonagano Y, Sakamoto T, Shima C, Matsumura M, Tanihara H (2008) Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study. Am J Ophthalmol 145:676–681. https://doi.org/10.1016/j.ajo.2007.12.010
Wang B, Dong N, Xu B, Liu J, Xiao L (2013) Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy. J Cataract Refract Surg 39:1691–1697. https://doi.org/10.1016/j.jcrs.2013.04.042
Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791–796. https://doi.org/10.1016/s0002-9394(03)00483-5
Mishra C, Lalitha P, Rameshkumar G, Agrawal R, Balne PK, Iswarya M, Kannan NB, Ramasamy K (2018) Incidence of endophthalmitis after intravitreal injections: Risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm 26:559–568. https://doi.org/10.1080/09273948.2018.1430238
Jonas JB, Kreissig I, Spandau UH, Harder B (2006) Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am J Ophthalmol 141:579–580. https://doi.org/10.1016/j.ajo.2005.10.007
Gills JP, Gills P (2005) Effect of intracameral triamcinolone to control inflammation following cataract surgery. J Cataract Refract Surg 31:1670–1671. https://doi.org/10.1016/j.jcrs.2005.07.023
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors. In addition, this type of study is exempt by the Institutional Review Board.
Informed consent
For this type of study, the formal consent is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chou, Yy., Zhang, Bl., Gan, Ly. et al. Efficacy of intracameral preservative-free triamcinolone acetonide in pediatric cataract surgery: a meta-analysis. Graefes Arch Clin Exp Ophthalmol 258, 2205–2212 (2020). https://doi.org/10.1007/s00417-020-04765-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-020-04765-x